Discovering novel small molecule and the demonstration of true non-clinical proof-of-concept is a key value-creation step in the clinical development of a medicine.
Business model based on discovering and developing novel drug candidate until Preclinical phase – with strong science data of Non-Clinical “Proof of concept" (PoC) and licensing them to the best possible commercial partner or new spin out companies.
Drug Discovery Factory
Micar Innovation is Drug Discovery Factory profitable and firmly anchored in its community. Micar Innovation business model and organization are predicated on the co-existence of four business streams /Licensing of our own Pipeline, Parthership, Project: 22 new treatments of rare and ultra rare diseases, Factory for Drug Discovery of novel compounds for the treatment of diversity diseases/ that respectively provide short, medium and long-term revenue streams.
Founded in 2016, Micar Innovation is built on a balanced business model. Micar Innovation capital is in the hands of its top management. Thus, the interests of its management remain perfectly aligned.